Decentralized Genomic Data Aggregation Platform
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current genomic and medical data aggregation systems face challenges such as data siloing, lack of transparency, and mistrust among stakeholders, leading to limited research potential and inefficient use of genetic and health data, with pharmaceutical companies often prioritizing proprietary interests over collaborative approaches.
Innovation Solution
A community ownership model utilizing blockchain technology to create a decentralized and transparent database where contributors have control over their data, earning cryptocurrency coins for contributions, and receiving a stake in the database, allowing for broad consent and transparent data usage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmaceutical companies maintain proprietary data silos to protect competitive advantage, then company-specific data security and intellectual property are improved, but overall research productivity and data sharing are reduced
Solution Approach 1:
The patent segments data access rights by creating different levels of access control. Sensitive personal identifiers are separated from genomic data, and access is segmented into authorized research purposes versus proprietary retention. This allows companies to share data for research while maintaining security controls over specific data elements and their usage.
Solution Approach 2:
The patent introduces an intermediary authorization framework that mediates between data contributors, pharmaceutical companies, and research entities. This intermediary system verifies identities, manages consent, and controls access without requiring direct trust relationships between all parties, enabling secure data sharing while maintaining company-specific security requirements.
2Adaptability or versatility
If broad consent is obtained for data usage, then research versatility and data utility are improved, but participant control and privacy protection become more difficult to maintain
Solution Approach 1:
The patent implements dynamic consent management that allows participants to modify their authorization preferences over time. Consent is not static but can be updated, expanded, or restricted as needed. This dynamic system maintains participant control while enabling broad data utility, as participants can initially provide broad consent and later adjust their preferences without being locked into initial decisions.
Solution Approach 2:
The patent incorporates feedback mechanisms where participants receive information about how their data is being used and can provide ongoing input. This feedback loop maintains participant engagement and control, allowing them to understand the utility of their data contribution while retaining the ability to modify consent based on their evolving preferences and understanding.
3Reliability
If data is aggregated from multiple sources to increase statistical power, then research reliability and discovery potential are improved, but data quality variation and integration complexity increase
Solution Approach 1:
The patent applies homogeneity principles by establishing standardized data formats, quality thresholds, and validation rules that normalize diverse data sources. Before aggregation, data from different contributors is transformed into a common structure with consistent quality standards, reducing integration complexity while maintaining the statistical power benefits of multi-source aggregation.
Solution Approach 2:
The patent changes key parameters of data integration by implementing automated quality assessment metrics, standardized encoding schemes, and validation protocols. These parameter changes transform heterogeneous data into a unified format suitable for aggregation, reducing the complexity of integrating data from multiple sources while preserving the statistical power gained from diverse contributions.
4Ease of operation
If decentralized community ownership is implemented, then participant trust and data sharing are improved, but system complexity and coordination requirements increase
Solution Approach 1:
The patent implements a universal authorization framework that serves multiple functions simultaneously: it manages participant consent, controls data access, verifies identities, and enforces usage policies across different organizations. This multi-functional system reduces coordination complexity by providing a single standardized mechanism that handles multiple coordination requirements rather than requiring separate systems for each function.
Data Source
AI summary
A system and method are disclosed for the collection and aggregation of genomic, medical, and other data of interest for individuals and populations that may be of interest for analysis, research, pharmaceutical development, medical treatment, and so forth. Contributors become members of a community upon creation of an account and providing of data or files. The data is received and processed, such as to analyze, structure, perform quality control, and curate the data. Value or shares in one or more community databases are computed and attributed to each contributing member. The data is controlled to avoid identification or personalization. Third parties interested in the database information may contribute value (e.g., pay) for access and use. Value flows back to the members and to a system administrative entity.